AP NEWS

Global 2018 Urticaria Epidemiology & Patient Flow Analysis Market Report - Forecast to 2026 - ResearchAndMarkets.com

June 11, 2018

DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The “Global Urticaria Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.

The research provides insights into Urticaria epidemiology, Urticaria diagnosed patients, and Urticaria treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Urticaria derived from epidemiological analysis, patients diagnosed with Urticaria, and patients treated with a drug therapy.

The research study helps executives estimate Urticaria market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Urticaria prevalence, Urticaria diagnosis rate, and Urticaria treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report

Urticaria Patient Flow Urticaria Prevalence Urticaria Diagnosed Patients Urticaria Treated Patients

Key Topics Covered

1. Urticaria: Disease Definition

2. Global Urticaria Patient Flow

2A. Global Urticaria Prevalence

2B. Global Urticaria Diagnosed Patients

2C. Global Urticaria Treated Patients

3. Urticaria Patient Flow in the US

3A. Urticaria Prevalence in the US

3B. Urticaria Diagnosed Patients in the US

3C. Urticaria Treated Patients in the US

4. Urticaria Patient Flow in Europe

4A. Urticaria Prevalence in Europe

4B. Urticaria Diagnosed Patients in Europe

4C. Urticaria Treated Patients in Europe

5. Urticaria Patient Flow in Germany

5A. Urticaria Prevalence in Germany

5B. Urticaria Diagnosed Patients in Germany

5C. Urticaria Treated Patients in Germany

6. Urticaria Patient Flow in France

6A. Urticaria Prevalence in France

6B. Urticaria Diagnosed Patients in France

6C. Urticaria Treated Patients in France

7. Urticaria Patient Flow in Spain

7A. Urticaria Prevalence in Spain

7B. Urticaria Diagnosed Patients in Spain

7C. Urticaria Treated Patients in Spain

8. Urticaria Patient Flow in Italy

8A. Urticaria Prevalence in Italy

8B. Urticaria Diagnosed Patients in Italy

8C. Urticaria Treated Patients in Italy

9. Urticaria Patient Flow in UK

9A. Urticaria Prevalence in UK

9B. Urticaria Diagnosed Patients in UK

9C. Urticaria Treated Patients in UK

10. Urticaria Patient Flow in Japan

10A. Urticaria Prevalence in Japan

10B. Urticaria Diagnosed Patients in Japan

10C. Urticaria Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/bj2m2n/global_2018?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180611006169/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/11/2018 04:26 PM/DISC: 06/11/2018 04:26 PM

http://www.businesswire.com/news/home/20180611006169/en

AP RADIO
Update hourly